NCT03696407View on ClinicalTrials.gov

A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK

CompletedOBSERVATIONAL
Enrollment

108

Participants

Timeline

Start Date

December 20, 2018

Primary Completion Date

August 1, 2019

Study Completion Date

August 1, 2019

Conditions
Advanced Renal Cell Carcinoma
Trial Locations (6)

BN2 5BE

Royal Sussex County Hospital, Brighton

CB2 0QQ

Addenbrooke's Hospital, Cambridge

G12 0YN

Beatson West of Scotland Cancer Centre, Glasgow

GU27XX

Royal Surrey County Hospital, Guildford

EC1A 7BE

St Bartholomew's Hospital, London

M20 4BX

The Christie Hospital, Manchester

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY

NCT03696407 - A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK | Biotech Hunter | Biotech Hunter